Abstract: Aspirin with clopidogrel is a standard therapy for acute coronary syndrome and percutaneous coronary intervention. DAPT (dual antiplatelet therapy) effectively inhibit platelet activation and reduce ischemic stroke compared to antiplatelet monotherapy. However, DAPT carries an increased risk of bleeding like intracranial haemorrhage. The use of DAPT over long term determines the major systemic bleeding events. Physicians should assess benefits and risk with DAPT over monotherapy in ischemic stroke patients.
Keywords: aspirin, clopidogrel, dual antiplatelet therapy, ischemic stroke.
Title: A REVIEW ON BENEFICIAL EFFECTS OF DUAL ANTI-PLATELET THERAPY FOR TIA
Author: PRIYANKA.A, RAGASUDHA.A, Dr. MEBIN ALIAS
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
